|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02370 REDCO HEALTHY
Nominal 
0.410 -0.045 (-9.890%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 212,119 | -9.021% | 449,273 | 437,113 | 354,327 | 221,610 |
| Cost of Sales | (154,940) | -4.198% | (323,601) | (294,239) | (238,558) | (144,808) |
| Gross Profit | 57,179 | -19.942% | 125,672 | 142,874 | 115,769 | 76,802 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (13,807) | 65.492% | (63,389) | (69,151) | (3,487) | (1,441) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 637 | 79.944% | 1,580 | 1,055 | 2,145 | 913 | |
| Profit / (Loss) before Taxation | 11,621 | -60.228% | 6,934 | 16,037 | 59,271 | 57,921 | |
| Taxation | (3,898) | -52.752% | (6,667) | (6,084) | (19,138) | (13,911) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (6,650) | -9.277% | (10,250) | (6,764) | (7,993) | (4,398) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,073 | -92.133% | (9,983) | 3,189 | 32,140 | 39,612 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (162) | -- | 615 | 1,036 | 418 | (151) |
| Depreciation & Amortisation | 7,308 | 18.926% | 15,579 | 11,725 | 10,577 | 1,054 |
| Directors' Emoluments | -- | -- | 3,406 | 2,314 | 134 | 0 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 0.540 | -92.082% | -4.990 | 1.700 | 21.430 | 26.410 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.406 | (0.167) | 0.234 | -- |
| NBV per share ($) | 1.464 | -- | 1.456 | 1.504 | -- | -- |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 1,073,000 |
| %Change | -92.133% |
| EPS / (LPS) | RMB 0.005 |
| NBV Per Share (¥) | RMB 1.464 |